v3.26.3
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of liabilities at fair value on a recurring basis The following tables present information about the Company’s liabilities that are measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025 and indicate the fair value hierarchy level of the valuation techniques and inputs that the Company utilized to determine such fair value:
September 30, 2026
Quoted Prices in Active Markets
Significant Other Observable Input
Significant Other Unobservable Inputs
(Level 1)
(Level 2)
(Level 3)
(in thousands)
Liabilities
Private placement warrants - Issued March 2023
— 
— 
17,320 
Sponsor Shares
— 
— 
2,161 
$
— 
$
— 
$
19,481 
December 31, 2025
Quoted Prices in Active Markets
Significant Other Observable Input
Significant Other Unobservable Inputs
(Level 1)
(Level 2)
(Level 3)
(in thousands)
Liabilities
Public warrants
$
810 
$
— 
$
— 
Private placement warrants - Issued October 2019
— 
— 
245 
Private placement warrants - Issued March 2023
— 
— 
16,843 
Sponsor Shares
— 
— 
2,750 
$
810 
$
— 
$
19,838 
Schedule of change sin the fair value of Level 3 liabilities The following is a summary of changes in the fair value of the Level 3 liabilities during the nine months ended September 30, 2026 and 2025:
Sponsor Shares
Private placement warrants - Issued October 2019
Private placement warrants - Issued March 2023
(in thousands)
Balance as of January 1, 2026
$
2,750 
$
245 
$
16,843 
Warrant exercises
— 
— 
(235)
(Gain) loss from changes in fair value
(589)
(245)
712 
Balance as of September 30, 2026
$
2,161 
$
— 
$
17,320 
Sponsor Shares
Private Placement Warrants - Issued October 2019
Private Placement Warrants - Issued March 2023
(in thousands)
Balance as of January 1, 2025
$
1,703 
$
713 
$
13,820 
Warrant exercises
— 
— 
(10,961)
Loss from changes in fair value
1,852 
198 
16,791 
Balance as of September 30, 2025
$
3,555 
$
911 
$
19,650